A Review of Acute Myocardial Injury in Coronavirus Disease 2019
- PMID: 32642342
- PMCID: PMC7336683
- DOI: 10.7759/cureus.8426
A Review of Acute Myocardial Injury in Coronavirus Disease 2019
Abstract
In December 2019, an outbreak of pneumonia caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), occurred in Wuhan, Hubei province, China, and it has spread rapidly across the world, causing the coronavirus disease 2019 (COVID-19) pandemic. Although SARS-CoV-2 infection predominantly results in pulmonary issues, accumulating evidence suggests the increased frequency of a variety of cardiovascular complications in patients with COVID-19. Acute cardiac injury, defined as elevated cardiac troponin levels, is the most reported cardiac abnormality in COVID-19 and strongly associated with mortality. In this article, we summarize the currently available data on the association of SARS-CoV-2 and COVID-19 with acute myocardial injury.
Keywords: acute myocardial injury; cardiac troponin; covid-19; myocarditis; sars-cov-2.
Copyright © 2020, B K et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Similar articles
-
Cardiovascular risk and complications associated with COVID-19.Am J Cardiovasc Dis. 2020 Oct 15;10(4):479-489. eCollection 2020. Am J Cardiovasc Dis. 2020. PMID: 33224599 Free PMC article. Review.
-
Molecular Insights Into SARS COV-2 Interaction With Cardiovascular Disease: Role of RAAS and MAPK Signaling.Front Pharmacol. 2020 Jun 3;11:836. doi: 10.3389/fphar.2020.00836. eCollection 2020. Front Pharmacol. 2020. PMID: 32581799 Free PMC article. Review.
-
A comparison of COVID-19, SARS and MERS.PeerJ. 2020 Aug 19;8:e9725. doi: 10.7717/peerj.9725. eCollection 2020. PeerJ. 2020. PMID: 32879801 Free PMC article.
-
COVID-19 Outbreak in Malaysia.Osong Public Health Res Perspect. 2020 Jun;11(3):93-100. doi: 10.24171/j.phrp.2020.11.3.08. Osong Public Health Res Perspect. 2020. PMID: 32494567 Free PMC article. Review.
-
Coronavirus disease 2019 and cardiovascular system: A narrative review.Int J Cardiol Heart Vasc. 2020 Jun 3;29:100557. doi: 10.1016/j.ijcha.2020.100557. eCollection 2020 Aug. Int J Cardiol Heart Vasc. 2020. PMID: 32550259 Free PMC article. Review.
Cited by
-
The cardiovascular aspect of COVID-19.Ann Med. 2021 Dec;53(1):227-236. doi: 10.1080/07853890.2020.1861644. Ann Med. 2021. PMID: 33345626 Free PMC article. Review.
-
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis.Eur Heart J. 2022 Mar 14;43(11):1033-1058. doi: 10.1093/eurheartj/ehab696. Eur Heart J. 2022. PMID: 34791157 Free PMC article. Review.
-
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis.Cardiovasc Res. 2022 May 6;118(6):1385-1412. doi: 10.1093/cvr/cvab342. Cardiovasc Res. 2022. PMID: 34864874 Free PMC article. Review.
-
COVID-19 and Cardiovascular Disease: From Bench to Bedside.Circ Res. 2021 Apr 16;128(8):1214-1236. doi: 10.1161/CIRCRESAHA.121.317997. Epub 2021 Apr 15. Circ Res. 2021. PMID: 33856918 Free PMC article. Review.
-
ST-Elevation Myocardial Infarction in a 27-Year-Old Male With COVID-19.Cureus. 2020 Sep 11;12(9):e10384. doi: 10.7759/cureus.10384. Cureus. 2020. PMID: 33062505 Free PMC article.
References
-
- WHO: novel coronavirus (COVID-19) situation reports. [May;2020 ];5] S. I. N. http://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation... vol. 2019, no. April. 2020
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous